HTG Molecular Diagnostics Announces Pricing of a $10 Million Public Offering

TUCSON, Ariz. , Dec. 21, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medicinal chemistry technology, today announced the pricing of a public